Gastroenterology Review
eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
4/2025
vol. 20
 
Share:
Send email
Share:
Original paper

Fecal butyric acid as a predictive biomarker of endoscopic remission in inflammatory bowel disease: a multicenter prospective study

Katarzyna Karłowicz
1
,
Konrad Lewandowski
1
,
Danuta Domżał-Magrowska
2
,
Renata Talar-Wojnarowska
2
,
Karolina Skonieczna-Żydecka
3
,
Wojciech Marlicz
4
,
Ewa Małecka-Wojciesko
2
,
Grażyna Rydzewska
1, 5

  1. Department of Gastroenterology and Internal Medicine, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland
  2. Department of Digestive Tract Diseases, Medical University of Lodz, Poland
  3. Department of Biochemical Science, Pomeranian Medical University, Szczecin, Poland
  4. Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland
  5. Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Gastroenterology Rev 2025; 20 (4): 443–448
DOI: https://doi.org/10.5114/pg.2025.158047
Online publish date: 2025/12/17
Article file
- Fecal butyric acid.pdf  [0.10 MB]
Get citation
 
PlumX metrics:
 
1. Łodyga M, Eder P, Gawron-Kiszka M, et al. Guidelines for the management of patients with Crohn’s disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology. Gastroenterology Rev 2021; 16: 257-96.
2. Eder P, Łodyga M, Gawron-Kiszka M, et al. Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology. Gastroenterology Rev 2023; 18: 1-42.
3. Raine T, Bonovas S, Burisch J, et al. ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J Crohns Colitis 2022; 16: 2-17.
4. Torres J, Bonovas S, Doherty G, et al. ECCO guidelines on therapeutics in crohn’s disease: medical treatment. J Crohns Colitis 2020; 14: 4-22.
5. Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 2021; 160: 1570-83.
6. Liu D, Saikam V, Skrada KA, et al. Inflammatory bowel disease biomarkers. Med Res Rev 2022; 42: 1856-87.
7. Jukic A, Bakiri L, Wagner EF, et al. Calprotectin: from biomarker to biological function. Gut. 2021; 70: 1978-1988.
8. Sakurai T, Saruta M. Positioning and usefulness of biomarkers in inflammatory bowel disease. Digestion 2023; 104: 30-41.
9. Kaczmarczyk O, Dąbek-Drobny A, Woźniakiewicz M, et al. Altered fecal short‑chain fatty acid profile as a potential marker of disease activity in patients with ulcerative colitis and Crohn’s disease: a pilot study. Pol Arch Intern Med 2022; 132: 16254.
10. Danne C, Skerniskyte J, Marteyn B, Sokol H. Neutrophils: from IBD to the gut microbiota. Nat Rev Gastroenterol Hepatol 2024; 21: 184-97.
11. Gaweł K, Dąbkowski K, Zawada I, et al. Natural history and progression risk factors of ulcerative proctitis: a retrospective study from a single tertiary centre in Poland. Gastroenterology Rev 2025; 20: 78-83.
12. Federici S, Kredo-Russo S, Valdés-Mas R, et al. Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation. Cell 2022; 185: 2879-98.e24.
13. Song M, Xia B, Li J. Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1, and nuclear factor B in trinitrobenzene sulphonic acid induced colitis in rats. Postgrad Med J 2006; 82: 130-5.
14. Jobin C, Balfour Sartor R. The IB/NF-B system: a key determinant of mucosal inflammation and protection. Am J Physiol Cell Physiol 2000; 278: 451-62.
15. Andoh A, Bamba T, Sasaki M. Physiological and anti-inflammatory roles of dietary fiber and butyrate in intestinal functions. J Parenter Enter Nutr 1999; 23: 70-3.
16. Segain J, Galmiche J, Raingeard De La Blétière D, et al. Butyrate inhibits inflammatory responses through NFB inhibition: implications for Crohn’s disease. Gut 2000; 47: 397-403.
17. Facchin S, Vitulo N, Calgaro M, et al. Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease. Neurogastroenterol Motil 2020; 32: e13914.
18. Huda-Faujan N, Abdulamir A, Fatimah A, et al. The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J 2010; 4: 53-8.
19. Firoozi D, Masoumi SJ, Mohammad-Kazem Hosseini Asl S, et al. Effects of short-chain fatty acid-butyrate supplementation on expression of circadian-clock genes, sleep quality, and inflammation in patients with active ulcerative colitis: a double-blind randomized controlled trial. Lipids Health Dis 2024; 23: 216.
20. Marshall JK, Thabane M, Steinhart AH, et al. Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2012; 11: CD004118.
Copyright: © 2025 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.